Molina Healthcare, Inc. (NYSE:MOH) – Analysts at Mitsubishi UFJ Financial Group raised their Q1 2019 EPS estimates for Molina Healthcare in a research report issued to clients and investors on Monday, January 7th. Mitsubishi UFJ Financial Group analyst J. Twizell now anticipates that the company will post earnings of $2.35 per share for the quarter, up from their previous forecast of $1.80. Mitsubishi UFJ Financial Group currently has a “Overweight” rating on the stock. Mitsubishi UFJ Financial Group also issued estimates for Molina Healthcare’s Q2 2019 earnings at $2.65 EPS, Q3 2019 earnings at $2.50 EPS, Q4 2019 earnings at $1.85 EPS, FY2019 earnings at $9.35 EPS and FY2020 earnings at $10.15 EPS.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, October 31st. The company reported $2.55 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.65 by $0.90. Molina Healthcare had a net margin of 1.27% and a return on equity of 30.50%. The firm had revenue of $4.70 billion for the quarter, compared to the consensus estimate of $4.72 billion. During the same period in the previous year, the company earned ($1.62) earnings per share. The company’s quarterly revenue was down 6.6% on a year-over-year basis.

Other equities analysts also recently issued reports about the stock. ValuEngine downgraded shares of Molina Healthcare from a “hold” rating to a “sell” rating in a report on Friday, December 21st. Piper Jaffray Companies upped their price objective on shares of Molina Healthcare to $165.00 and gave the company an “overweight” rating in a report on Wednesday, September 26th. JPMorgan Chase & Co. upgraded shares of Molina Healthcare from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $127.00 to $150.00 in a report on Tuesday. Wolfe Research downgraded shares of Molina Healthcare from an “outperform” rating to a “market perform” rating in a report on Thursday, January 3rd. Finally, Evercore ISI assumed coverage on shares of Molina Healthcare in a report on Tuesday, October 9th. They issued an “in-line” rating and a $158.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $140.92.

NYSE:MOH opened at $133.38 on Thursday. Molina Healthcare has a one year low of $71.07 and a one year high of $154.06. The firm has a market capitalization of $8.15 billion, a price-to-earnings ratio of 238.18, a P/E/G ratio of 1.26 and a beta of 1.62. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.40 and a current ratio of 1.40.

Institutional investors have recently made changes to their positions in the business. Advisors Asset Management Inc. grew its stake in Molina Healthcare by 2,264.2% during the second quarter. Advisors Asset Management Inc. now owns 93,813 shares of the company’s stock worth $118,000 after buying an additional 89,845 shares in the last quarter. Cerebellum GP LLC acquired a new stake in Molina Healthcare during the fourth quarter worth about $158,000. DekaBank Deutsche Girozentrale grew its stake in Molina Healthcare by 185.1% during the third quarter. DekaBank Deutsche Girozentrale now owns 1,226 shares of the company’s stock worth $170,000 after buying an additional 796 shares in the last quarter. Alpha Cubed Investments LLC acquired a new stake in Molina Healthcare during the third quarter worth about $200,000. Finally, Ibex Investors LLC acquired a new stake in Molina Healthcare during the third quarter worth about $200,000.

In related news, Director Ronna Romney sold 200 shares of the company’s stock in a transaction dated Monday, December 3rd. The shares were sold at an average price of $141.23, for a total value of $28,246.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Dale B. Wolf sold 4,000 shares of the company’s stock in a transaction dated Friday, November 9th. The shares were sold at an average price of $135.57, for a total transaction of $542,280.00. Following the completion of the transaction, the director now owns 10,214 shares in the company, valued at $1,384,711.98. The disclosure for this sale can be found here. Insiders sold 9,195 shares of company stock worth $1,187,506 over the last 90 days. 0.65% of the stock is currently owned by corporate insiders.

About Molina Healthcare

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

Read More: What Are Treasury Bonds?

Earnings History and Estimates for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.